Shanghai Juncell Therapeutics

This early-stage study tested a treatment made from a patient's own tumor-fighting immune cells, called tumor-infiltrating lymphocytes (TILs). It included 43 adults with advanced solid tumors like melanoma, cervical cancer, and lung cancer. The goal was to find the safest dose an…

This study tested a new treatment called GC101 TIL for people with advanced melanoma that did not respond to standard therapies. The treatment uses a patient's own immune cells, grown in a lab, to fight the cancer. The goal was to check safety and see if tumors shrink. 18 patient…

This study tested a new treatment for people with advanced gynecologic tumors that had stopped responding to standard therapies. Doctors took immune cells from each patient's tumor, modified them in the lab to make them stronger, and then infused them back into the patient. The g…